The Patent Finder

Janssen Vaccines & Prevention B.V.

68 patents currently held · Updated Nov 21, 2026
28 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

Previously recorded as Crucell Holland B.V. (to 2016)

2
Ending by 2030
Sep 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Nov 21, 2026
  • 1 fee due Dec 25, 2026
    The maintenance fee for Influenza virus vaccines and uses thereof (US 10,328,144) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
  • 1 fee due Jan 9, 2027
    The maintenance fee for Method for quantification of virus particles using capillary zone electrophoresis (US 10,345,259) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
  • 4 fees due Feb 1 to 22, 2027 · next Feb 1
  • 2 fees due Mar 19 to 24, 2027 · next Mar 19
  • 4 fees due Apr 10 to 30, 2027 · next Apr 10
  • 2 fees due May 12 to 21, 2027 · next May 12
  • 2 fees due Jun 30, 2027
  • 3 fees due Jul 2 to 21, 2027 · next Jul 2
  • 3 fees due Aug 13 to 25, 2027 · next Aug 13

Which patents, and when each one lapses · Pro

Recent changes

  • 2 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,005,831Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 8,470,327Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 9,611,317Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 9,701,718Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines
In force
 · High confidence
In forceHigh confidence
US 9,593,159Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses
In force
 · USPTO record
In forceUSPTO record
US 9,452,211Influenza virus vaccines and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 9,969,778Influenza virus vaccines and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 9,476,061Adenoviral vectors for transduction of vascular tissue
In force
 · USPTO record
In forceUSPTO record
US 10,294,279Stabilized soluble pre-fusion RSV F polypeptides
In force
 · USPTO record
In forceUSPTO record
US 10,272,032Adenovirus forumations
In force
 · USPTO record
In forceUSPTO record
10 of 68 patents shown.
Pro members see all 68.
Pro members: see all 68 patents
Also on record, not counted in the 68: 28 patents in force now held by others · 43 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 11 abandoned · 23 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited